Guaiacol is a smoky phenolic molecule found in wood smoke, guaiac-derived materials, and pyrolytic oils such as cade. In the AromaForge archive it is most relevant as a major phenolic marker in unrectified cade oil rather than as a gentle fragrance constituent. Public evidence is relatively strong for identity and fragrance-safety review, and there is also direct experimental literature on antimicrobial and antifungal activity, but those findings are preclinical and do not support medical-use claims.
Chemical identity and composition
PubChem identifies guaiacol as C7H8O2. The local cade-unrectified oil record cites a Canadian government assessment describing the oil's phenolic fraction as 17-26%, composed largely of guaiacol at about 12% plus cresols. This fits guaiacol's role as a smoky lignin-pyrolysis marker rather than a typical floral or citrus essential-oil component.
Aroma and practical use
- Use the recorded smoky, phenolic, medicinal, woody, creosote-like descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2021 full-text fungal study found that guaiacol inhibited mycelial growth, conidial formation, germination, and deoxynivalenol production in Fusarium graminearum in a dose-dependent manner, with an EC50 of 1.838 mM for the PH-1 strain.
This is the strongest direct isolated-compound bioactivity paper located in this pass and supports a chemistry-forward antifungal interpretation.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
A 2021 study comparing natural methoxyphenols reported that guaiacol showed antimicrobial activity against foodborne pathogens and spoilage bacteria, although eugenol was generally stronger in several assays.
The paper supports direct antimicrobial relevance for guaiacol while also showing that activity depends on structure and assay conditions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
The 2022 RIFM fragrance ingredient safety assessment concluded that existing information supports guaiacol's use as described in the assessment and reported no genotoxicity concern, exposure below sensitization threshold at declared use levels, and no expected phototoxicity or photoallergenicity.
This is the main public safety anchor for guaiacol under fragrance-use scenarios.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedA 2022 RIFM review concluded that guaiacol is not genotoxic and is not expected to be phototoxic or photoallergenic under the fragrance-use conditions evaluated.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Guaiacol is a phenolic material associated with smoky tar oils such as crude cade, so constituent context matters; oil-level safety concerns for unrectified cade include broader phenolic and PAH issues that go beyond guaiacol alone.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
membrane_disruption_and_calcium_transport_interference_in_fungi
A Frontiers microbiology study linked guaiacol's antifungal effect in Fusarium graminearum to membrane damage and disruption of Ca2+ transport channels.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
radical_scavenging_and_redox_activity
Guaiacol's phenolic structure is commonly studied for antioxidant redox behavior, which likely contributes to some of its preservative and bioactivity literature.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- This pass did not verify human clinical efficacy evidence for isolated guaiacol.
- Most accessible direct functional studies involve microbes, chemical assays, or formulation-safety review rather than translational human outcomes.
- Safety interpretation should distinguish isolated guaiacol from harsher pyrolytic oil mixtures that contain additional hazardous constituents.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.